In particular, lower levels of vascular endothelial growth factor (VEGF) were measured in the cerebrospinal fluid (CSF) of early ALS patients (i.e., during the first year of the disease), compared with controls [101]. This evidence concerns the gene VEGFA and amyotrophic lateral sclerosis.